The hosts compare the current Ozempic craze to the 1990s Fen-Phen scandal, which resulted in massive lawsuits due to heart valve failure. They speculate that Pfizer's failure to produce a competing weight-loss drug may lead to increased regulatory and legal pressure on Novo Nordisk.